Type
|
Public |
---|---|
Traded as | NASDAQ: ALOG S&P 600 Component |
Industry | Medical Imaging Ultrasound Security |
Founded | Wakefield, Massachusetts (1967) |
Headquarters | Peabody, Massachusetts |
Key people
|
Fred Parks, President & CEO Bernard Bailey, Chairman of the Board |
Products | Medical & Security Imaging Systems and Subsystems; Ultrasound Systems & Transducers |
Revenue | $517.5 million USD (Fiscal 2014) |
Number of employees
|
1,500 |
Website | www.analogic.com |
Analogic is an American multinational corporation. Analogic Corporation currently employs 1,500 employees worldwide with approximately 900 working at the main facility and headquarters in Peabody, Massachusetts.
When Bernard M. Gordon, chairman emeritus, founded Analogic in 1967, his inventions had already made their mark in history. That tradition of inventiveness has continued ever since. Today, Analogic has a long list of innovations and achievements resulting from more than 40 years of developing leading-edge technologies. Analogic is an innovator in computed tomography signal processing and a recognized leader in diagnostic medical imaging and security imaging. With over 190 U.S. patents issued, with corresponding foreign patents, and many more pending, Analogic's history speaks for itself.
Analogic provides health care and security technology solutions to advance the practice of medicine and save lives. Analogic is recognized around the world for advanced imaging systems and technology that enable computed tomography (CT), ultrasound, digital mammography, and magnetic resonance imaging (MRI), as well as automated threat detection for aviation security. The company's CT, MRI, digital mammography, and ultrasound transducer products are sold to original equipment manufacturers (OEMs), providing state-of-the-art capability and enabling them to enter new markets and expand their existing market presence. Its BK Medical branded ultrasound systems, used in procedure-driven markets such as urology, guided surgery, and anesthesia, are sold to clinical end users through Analogic's direct sales force.
2016-06-02 | Reiterated Rating | Brean Capital | Buy | |
2016-03-24 | Initiated Coverage | Sidoti | Neutral | $81.00 |
2016-03-03 | Reiterated Rating | Brean Capital | Buy | $90.00 |
2015-12-09 | Reiterated Rating | Brean Capital | Buy | $110.00 |
2015-11-23 | Lower Price Target | Benchmark Co. | $89.00 | |
2015-10-09 | Reiterated Rating | Brean Capital | Buy | |
2015-09-15 | Reiterated Rating | Brean Capital | Buy | $110.00 |
2015-06-04 | Upgrade | Brean Capital | Buy | $110.00 |
2015-03-24 | Upgrade | Wells Fargo & Co. | Market Perform to Outperform | |
2015-03-24 | Upgrade | Brean Capital | Hold to Buy | $110.00 |
2015-03-24 | Upgrade | Wells Fargo | Market Perform to Outperform | |
2015-03-11 | Reiterated Rating | Brean Capital | Hold | |
2015-02-11 | Reiterated Rating | Brean Capital | Hold | |
2014-09-16 | Downgrade | Brean Capital | Buy to Hold | $95.00 |
2014-06-06 | Reiterated Rating | Benchmark Co. | Buy | $105.00 to $91.00 |
2014-03-14 | Upgrade | Sidoti | Neutral to Buy | |
2014-03-07 | Downgrade | CJS Securities | Outperform to Market Perform | $97.00 to $90.00 |
2013-12-16 | Initiated Coverage | Brean Capital | Buy | $100.00 |
2013-10-21 | Boost Price Target | Benchmark Co. | Buy | $89.00 to $105.00 |
2012-09-14 | Upgrade | Needham | Hold to Buy | $85 |
2012-09-14 | Reiterated | The Benchmark Company | Buy | $82 to $90 |
2012-06-07 | Downgrade | Needham | Buy to Hold | $66 |
2012-03-29 | Reiterated | The Benchmark Company | Buy | $65 to $82 |
2012-03-07 | Reiterated | Needham | Buy | $62 to $66 |
2011-12-09 | Reiterated | The Benchmark Company | Buy | $60 to $65 |
2010-05-25 | Upgrade | The Benchmark Company | Hold to Buy | $40 to $50 |
2010-05-25 | Upgrade | Benchmark | Hold to Buy | $40 to $50 |
2010-03-26 | Initiated | Benchmark | Hold | |
2010-03-10 | Upgrade | Needham | Hold to Buy | $50 |
2010-01-14 | Upgrade | Dougherty & Company | Sell to Neutral | $30 to $40 |
2009-12-10 | Downgrade | Needham | Buy to Hold | |
2009-09-18 | Downgrade | Dougherty & Company | Neutral to Sell | $30 |
2009-08-05 | Downgrade | Stifel Nicolaus | Buy to Hold | |
2009-06-18 | Initiated | Dougherty & Company | Neutral | $40 |
2009-01-29 | Reiterated | Stifel Nicolaus | Buy | $65 to $60 |
2008-12-10 | Reiterated | Stifel Nicolaus | Buy | $75 to $65 |
2008-12-10 | Reiterated | Stanford Research | Hold | $44 to $34 |
2008-12-10 | Reiterated | Needham | Buy | $72 to $45 |
2008-11-03 | Downgrade | Stanford Research | Buy to Hold | $44 |
2016-06-02 | Reiterated Rating | Brean Capital | Buy | |
2016-03-24 | Initiated Coverage | Sidoti | Neutral | $81.00 |
2016-03-03 | Reiterated Rating | Brean Capital | Buy | $90.00 |
2015-12-09 | Reiterated Rating | Brean Capital | Buy | $110.00 |
2015-11-23 | Lower Price Target | Benchmark Co. | $89.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ALOG 16 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Fund Advisors | 1.03M |
BlackRock Institutional Trust Company, N.A. | 0.34M |
Numeric Investors LLC | 0.15M |
RUSSELL FRANK CO/ | 0.12M |
MANAGED ACCOUNT ADVISORS LLC | 98982 |
BlackRock Investment Management, LLC | 67671 |
BlackRock Group LTD | 28980 |
Airain ltd | 9078 |
Independent Portfolio Consultants, Inc. | 8784 |
Hutchin Hill Capital, LP | 7100 |
BLACKROCK ADVISORS LLC | 6557 |
Placemark Investments, Inc. | 5245 |
VTL Associates, LLC | 3367 |
CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. | 2000 |
FNY Managed Accounts LLC | 32 |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
Green James W President/CEO/Director | 0.15% (18790) | ALOG / HBIO / |
Peechatka Farley Sr VP-GM & Glbl Ultrasound Bus | 0.15% (18635) | ALOG / |
Fry John J President/CEO/Director | 0.15% (18201) | ALOG / |
VOBORIL EDWARD F | 0.13% (15631) | ALOG / |
PARKS FRED B | 0.09% (11742) | ALOG / |
Faltas Mervat Sr VP and GM-OEM Medical Group | 0.08% (9529) | ALOG / |
BAILEY BERNARD C | 0.06% (7282) | ALOG / |
MELIA KEVIN C | 0.06% (7242) | ALOG / ANET / GB / RSYS / |
BLACK JEFFREY P | 0.05% (6647) | ALOG / |
Vandebroek Sophie V. | 0.05% (6185) | ALOG / IDXX / |
ODLAND STEPHEN A | 0.04% (4576) | ALOG / GIS / |
Levitz Michael L Sr. VP-CFO & Treasurer | 0.03% (4331) | ALOG / PODD / |
Chandra Shalabh See Remarks | 0.03% (3317) | ALOG / |
Ryan James Patrick SVP, Global Operations | 0.02% (2354) | ALOG / |
Frost Mark T SVP, CFO & Treasurer | 0.01% (1442) | ALOG / ANGO / |
Bourque Michael J. See Remarks | 0.01% (990) | ALOG / |